Showing results (1941-1950 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 1, 1986
The activity of flavone acetic acid (NSC 347512) on human colon cancer cells in vitroB Drewinko, L Y Yang
Investigational New Drugs|January 1, 1986
Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugsB T Hill, R D Whelan
Investigational New Drugs|January 1, 1986
Phase II study of spirogermanium in patients with advanced colorectal carcinomaJ A Ajani, J S Faintuch, R K McClure, et al.
Investigational New Drugs|July 22, 2022
Clinical features, diagnosis, and management of dasatinib-induced nephrotic syndromeYang He, Weijin Fang, Zuojun Li, et al.
Investigational New Drugs|June 23, 2018
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2Tomoko Takimoto-Shimomura, Taku Tsukamoto, Saori Maegawa, et al.
Investigational New Drugs|June 23, 2018
Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cellsViviane A O Silva, Marcela N Rosa, Vera Miranda-Gonçalves, et al.
Investigational New Drugs|October 2, 2017
Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumorsTomohiro Nishina, Shunji Takahashi, Ryota Iwasawa, et al.
Investigational New Drugs|October 2, 2017
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapyFrancesco Pasqualetti, Alessandra Gonnelli, Martina Cantarella, et al.
Investigational New Drugs|October 2, 2017
The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cellsLudovica Taglieri, Giovanna Rubinacci, Anna Giuffrida, et al.
Investigational New Drugs|September 5, 2017
Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignanciesMeiqi Shi, Jing Sun, Jinsong Zhou, et al.
Pageof 372